Ufp Technologies (UFPT) Income from Continuing Operations (2010 - 2026)
Ufp Technologies (UFPT) reported Income from Continuing Operations of 17495000.0 for Q1 2026, up 1.81% on a YoY basis from 17184000.0 in Q1 2025, and little changed quarter-over-quarter from 17566000.0 in Q4 2025.
Ufp Technologies (UFPT) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Ufp Technologies has reported Income from Continuing Operations for 17 years, with the latest figure at 17495000.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Continuing Operations rose 1.81% year-over-year to 17495000.0; the trailing twelve-month figure through Mar 2026 stood at 68624000.0 (up 8.12% YoY), and the FY2025 full-year result was 68313000.0, up 15.82% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 17495000.0, roughly flat from 17566000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 19540000.0 in Q3 2022, with the low at 30673000.0 in Q4 2022.
- Historically, Income from Continuing Operations has averaged 11315705.88 across 5 years, with a median of 13552000.0 in 2024.
- The largest YoY upside for Income from Continuing Operations was 415.7% in 2022 against a maximum downside of 2252.49% in 2022.
- Ufp Technologies' Income from Continuing Operations stood at 30673000.0 in 2022, then surged by 137.84% to 11608000.0 in 2023, then jumped by 41.07% to 16375000.0 in 2024, then increased by 7.27% to 17566000.0 in 2025, then dropped by 0.4% to 17495000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 17495000.0 (Q1 2026), 17566000.0 (Q4 2025), and 16383000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Ufp Technologies | 1.85 Bn | 1.83 Bn | 44.36 Mn | 17.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.50 Mn |
| Dec 31, 2025 | 17.57 Mn |
| Sep 30, 2025 | 16.38 Mn |
| Jun 30, 2025 | 17.18 Mn |
| Mar 31, 2025 | 17.18 Mn |
| Dec 31, 2024 | 16.38 Mn |
| Sep 30, 2024 | 16.36 Mn |
| Jun 30, 2024 | 13.55 Mn |
| Mar 31, 2024 | 12.69 Mn |
| Dec 31, 2023 | 11.61 Mn |
| Sep 30, 2023 | 11.69 Mn |
| Jun 30, 2023 | 11.88 Mn |
| Mar 31, 2023 | 9.74 Mn |
| Dec 31, 2022 | -30.67 Mn |
| Sep 30, 2022 | 19.54 Mn |
| Jun 30, 2022 | 8.93 Mn |
| Mar 31, 2022 | 4.86 Mn |
| Dec 31, 2021 | 1.43 Mn |
| Sep 30, 2021 | 3.79 Mn |
| Jun 30, 2021 | 4.72 Mn |